Xu Jingren

In this Chinese name, the family name is Xu.

Xu Jingren (Chinese: 徐镜人; September 15, 1944 – July 12, 2021) was the chairman and president of Yangtze River Pharmaceutical Group,^[1] National People's Congress delegate and honorary vice-minister in China's Ministry of Health. Xu had been an outspoken research leader in China, where he had frequently called for labor reform and business regulation.^[2] As of 2021, his estimated net worth was USD$4.6 billion,^[3] one of four family members to be listed among the world's wealthiest. He died on 12 July 2021.^[4]

Xu Jingren
徐镜人
Born	15 September 1944 Taizhou, Jiangsu, China
Died	12 July 2021(2021-07-12) (aged 76)
Education	B.A.
Occupation(s)	Pharmaceutical executive, philanthropist
Children	2

Personal life

The family were noted victims of the 2015 Chinese stock market crash, during which they lost approximately 40% of their previously estimated USD$8 billion combined net worth.^[5] Despite this, Xu Jingren and his relatives continue to be mentioned as one of China's top "vampire billionaire" families with majority investments abroad.^[6][7][8] Notable international initiatives include the 2017 YRPG subsidiary^[9] merger and rebranding of global drug manufacturer ShangPharma^[10] by group CEO Michael Hui and board vice-chair Aaron Shang, with a stated intent of expanding North American operations leading to development of San Francisco-based venture portfolio ShangPharma Innovation.^[11][12][13]